At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role in a significant number of opioid deaths each year with no solution currently available. Working with our Clinical subsidiary 4P Therapeutics we have developed a technology called AVERSA which we believe with FDA approval will revolutionize the safety standard for these medications and save countless lives per year.
| Website | https://nutriband.com |
| Ticker | NTRB |
| Revenue | $371000 |
| Employees | 9 (3 on RocketReach) |
| Founded | 2012 |
| Address | 121 S Orange Ave, Orlando, Florida 32801, US |
| Phone | (407) 377-6695 |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Health Care, Drug Delivery, Pharmaceuticals, Medical, Healthcare, Pharmaceutical |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, AstraZeneca, AbbVie, Johnson & Johnson, GSK, Purdue Pharma L.P., Merck AH +47 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies |
Looking for a particular Nutriband Inc. employee's phone or email?
The Nutriband Inc. annual revenue was $371000 in 2026.
Alan Smith is the Chief Operating Officer, Nutriband and President, 4P Therapeutics Subsidiary of Nutriband Inc..
3 people are employed at Nutriband Inc..
Nutriband Inc. is based in Orlando, Florida.
The NAICS codes for Nutriband Inc. are [54, 3254, 325, 32, 32541, 541].
The SIC codes for Nutriband Inc. are [28, 283].